Sterling Biotech Profile
Key Indicators
- Authorised Capital ₹ 2,800.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 643.35 Cr
as on 14-12-2024
- Company Age 39 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 60.90 Cr
as on 14-12-2024
- Satisfied Charges ₹ 21,734.44 Cr
as on 14-12-2024
- Revenue -24.01%
(FY 2017)
- Profit 12.00%
(FY 2017)
- Ebitda -80.49%
(FY 2017)
- Net Worth -47.09%
(FY 2017)
- Total Assets 14.99%
(FY 2017)
About Sterling Biotech
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 512299.
The Corporate was formerly known as Pluto Exports & Consultants Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2,800.00 Cr and a paid-up capital of Rs 643.35 Cr.
The company currently has active open charges totaling ₹60.90 Cr. The company has closed loans amounting to ₹21,734.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sterling Biotech Limited India are Devesh Choudhari as CFO and Heenaben Pankhania as Company Secretary. Aftab Mathur, Perumal Gandhi, Vishal Gor, and Three other members serve as directors at the Company.
- CIN/LLPIN
L51900MH1985PLC035738
- Company No.
035738
- Stock Symbol
BSE : 512299
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Mar 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sterling Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devesh Choudhari | CFO | 27-May-2024 | Current |
| Heenaben Pankhania | Company Secretary | 17-Aug-2023 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aftab Mathur  | Nominee Director | 29-Aug-2024 | Current |
| Perumal Gandhi | Director | 17-Nov-2022 | Current |
| Vishal Gor | Nominee Director | 29-Aug-2024 | Current |
| Keyur Parekh | Nominee Director | 29-Aug-2024 | Current |
Narayan Mahadeva  | Director | 30-Sep-2023 | Current |
| Alok Garg | Nominee Director | 29-Aug-2024 | Current |
Financial Performance and Corporate Structure Insights of Sterling Biotech.
Sterling Biotech Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 24.01% decrease. The company also saw a substantial improvement in profitability, with a 12% increase in profit. The company's net worth observed a substantial decline by a decrease of 47.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sterling Biotech?
In 2017, Sterling Biotech had a promoter holding of 25.92% and a public holding of 74.08%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Evolutionx Debt Capital Advisors India Private LimitedActive 1 year 5 monthsAftab Mathur is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 28 Nov 2023 | ₹22.50 Cr | Open |
Hdfc Bank Limited Creation Date: 19 Oct 2023 | ₹14.40 Cr | Open |
Others Creation Date: 03 Oct 2023 | ₹24.00 Cr | Open |
How Many Employees Work at Sterling Biotech?
Sterling Biotech has a workforce of 369 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sterling Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterling Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
